Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

MLA

Kenji Sawa, et al. “Predictive Impact of Low-Frequency Pretreatment T790M Mutation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors.” Lung Cancer (Amsterdam, Netherlands), vol. 139, July 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79be99440294b0c71209d938fd46322b&authtype=sso&custid=ns315887.

APA

Kenji Sawa, Yoshiya Matsumoto, Tomohiro Suzumura, Nobuyuki Yamamoto, Mitsuru Fukui, Naoki Yoshimoto, Kazuhisa Asai, Hiroyasu Kaneda, Jun Oyanagi, Tetsuya Watanabe, Yasuhiro Koh, Tomoya Kawaguchi, Shigeki Mitsuoka, Kazuto Hirata, & Tatsuo Kimura. (2019). Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors. Lung Cancer (Amsterdam, Netherlands), 139.

Chicago

Kenji Sawa, Yoshiya Matsumoto, Tomohiro Suzumura, Nobuyuki Yamamoto, Mitsuru Fukui, Naoki Yoshimoto, Kazuhisa Asai, et al. 2019. “Predictive Impact of Low-Frequency Pretreatment T790M Mutation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors.” Lung Cancer (Amsterdam, Netherlands) 139 (July). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79be99440294b0c71209d938fd46322b&authtype=sso&custid=ns315887.